Showing posts with label Healthcare-Pharmaceuticals. Show all posts
Showing posts with label Healthcare-Pharmaceuticals. Show all posts

Monday, 4 February 2019

Global Cancer Supportive Drugs Market, Trends & Analysis – Forecasts To 2026


The market report is designed to provide a complete view of the global Cancer Supportive Drugs Market. This business intelligence report has been categorized into qualitative and quantitative insights over the forecast period (2018-2026). The report provides the following market insights which enable the enterprises and consumers to make strategic business decisions -
Strategic Market Entry - We provide detailed research support to our clients including mapping the product life cycle, key market players, consumer behaviour, and analysis of the company’s market position.
Sales Maximization - The market research report explores different avenues of maximizing sales through threat evaluation, identifying potential clients and distributors and market risks. The report provides qualitative insights into the market scenario which in turn enables the customer to evaluate business profitability.
Consumer & Competitive Scenario - As a part of consumer analysis, the report provides macro as well as micro-level insights about consumer demand, and product preferences. Companies profiled in the report include a detailed analysis of their financial performance, strategic initiatives, and SWOT analysis. Porter’s analysis provides’ market intelligence to evaluate competitive threat.
Market Estimates & Forecasts - Quantitative analysis holds a major section of the market research report. The report analyses every business segment, its market drivers and restraints, market expansion opportunities and growth rates. The report also provides a region-wise and country-wise break-up of the global market and business segments.
Vendor and Customer analysis - The report identifies the key vendors in the market along with their product portfolio, patents held by them, their market presence and extent of distribution network. This chapter enables enterprises to choose the most suitable vendor to cater to their needs and requirements.
Cancer Supportive Drugs Market

The qualitative chapters in the report include the demand and supply matrix consisting of analysis of broad level market drivers, opportunities, threats and challenges. The report considers short-term as well as long term factors influencing the market demand. The market segments and their respective estimates & forecasts have been covered under the quantitative information category. Forecasts & trend analysis for each country and region is also available in the study. The report concludes by providing competitor analysis for major market participants profiled by analyzing their organic & inorganic growth strategies, regional presence, and product portfolio among others.
Vendor Landscape: Cancer Supportive Drugs Market
The report contains a chapter dedicated to vendors operating in the market, covering equipment developers, manufacturers, and distributors. The report provides these insights on a regional level. This section of the report entails contact details, experience, products manufactured/supplied, and geographical presence of companies.
End-User Landscape (Consumer Profile): Cancer Supportive Drugs Market
The report provides a detailed list of end-users operating across the world. The end-user landscape includes consumer contact details, geographical presence, revenue, product portfolio, organic and inorganic growth strategies among others.
Company Profiles: Cancer Supportive Drugs Market
The major companies profiled in the Cancer Supportive Drugs Market include Amgen, Johnson & Johnson, Merck, Roche, Helsinn Healthcare, Novartis, Heron Pharma, Tesaro and Cinvanti, among others. Companies are investing in innovation/R&D, brand building, and fostering strong relationships with customers to enhance their competitive position.


Monday, 28 January 2019

Global Teeth Whitening Market, Trends & Analysis – Forecasts To 2026

Teeth Whitening Market Insights
The global teeth whitening market is estimated to witness a moderate CAGR during the forecast period. The market is driven by growing awareness about physical appearance coupled with the convenience provided by non-invasive teeth whitening products. Teeth whitening products essentially bleach the teeth, making them whiter and more presentable. Teeth whiteners can be applied by a dentist, and can also be bought over the counter and applied by the consumer at home. These products are available in a variety of ranges and price points, which make them accessible to all kinds of consumers. Easy availability of these products is expected to further contribute to growth in the teeth whitening market. however, factors such as lack of knowledge and awareness about teeth whitening is expected to hinder growth in the market especially in developing countries.
Teeth Whitening Market

Teeth Whitening Market: By Product
The global Teeth Whitening market can be broadly segmented into whitening toothpastes, whitening gels and strips and white light teeth whitening devices among others. The teeth whitening toothpastes segment is projected to hold the largest market share in terms of revenue during the forecast period. Toothpastes are a highly popular product and are used extensively in low and middle income countries. Due to high demand and lower price of the product, teeth whitening toothpastes are more likely to be purchased in these regions. The demand for teeth whitening strips is estimated to grow at a significant CAGR owing to its effectiveness and availability in drugstores.
Teeth Whitening Market: By Distribution Channel
On the basis of distribution channel, the global teeth whitening market can be classified into online sales and offline sales. Although online methods of purchasing consumer goods have gained tremendous traction recently, the offline sales are likely to dominate the market share in terms of revenue. This can be attributed to lack of access to online platforms in developing and less developed economies. The online sales segment is projected to be the fastest growing, owing to wide variety of products available online and convenience offered by online shopping.
Teeth Whitening Market: Regional Insights
North America is projected to hold the largest market share in the global teeth whitening market due to inclination of the population towards improving aesthetic appearance through cosmetic dentistry. U.S. is expected to be the largest contributors towards growth in the teeth whitening market in North America. Rise in teeth damage due to unhealthy lifestyle and consumption of junk food is further expected to boost demand for teeth whitening products in the region. Easy access to healthcare and over the counter teeth whitening products is likely to have a positive impact on growth in the market as well.
Teeth Whitening Market: Vendor Landscape
The report contains a chapter dedicated to vendors operating in the market, covering raw material manufactures, equipment developers, manufacturers, and distributors. The report provides these insights on a regional level. This section of the report entails contact details, experience, products manufactured/supplied, and geographical presence of companies.
Teeth Whitening Market: Share & Competitor Analysis
Some of the key players operating in the Teeth Whitening market are Colgate-Palmolive, GlaxoSmithKline, Johnson & Johnson, Proctor & Gamble, Unilever, GLO Science, Henkel, Church & Dwight, and Brodie & Stone.
In August 2018, Proctor & Gamble was granted a patent for its teeth whitening device which uses blue visible light or near-visible ultraviolet light to speed bleaching when peroxide-based substances are applied
In June 2017, the American Dental Association announced the Crest 3D Glamorous White Whitestrips to be the only home-use teeth whitening product to be accepted by the ADA
Browse this report @: https://www.globalmarketestimates.com/global-teeth-whitening-market-size

Monday, 13 August 2018

Obstetrics Devices Market Size & Analysis – Forecasts To 2025

Obstetrics Devices Market Insights
The global obstetrics devices market is expected to grow at a moderate CAGR over the forecast period. Rising number of assisted deliveries owing to the growing presence of PCOS, obesity and preterm birth among other gynecological problems is likely to boost the growth of overall obstetrics devices industry. Moreover, rising incidence of physical injuries including tears and lacerations to injured pelvic organs, mostly among first-time mothers and women with a previous C-section is likely to contribute towards the profitability of the industry.

Factors such as rising birth rates coupled with increasing cases of heart diseases among women are also projected to stimulate demand for obstetrics devices.

Factors such as stringent regulations associated with the safety, efficacy, and accuracy of the obstetrics devices by various health organizations are likely to restrain the market growth to a certain extent.



Obstetrics Devices Market

Obstetrics Devices Market: Delivery Type Insights
The global obstetrics devices market is segmented into normal and cesarean, based on delivery type. Cesarean or C-section deliveries are likely to grow at a considerable rate over the forecast period. Increasing number of high-risk expectant mothers coupled with the growing obstetrical medico-legal environment in regions such as the Asia Pacific is projected to contribute potentially towards the overall market growth. Along with this, rising cases of cesareans performed for the maternal request is also expected to be one of the major influencing factors affecting the sector.

 Request for a sample copy of the report at: https://www.globalmarketestimates.com/obstetrics-devices-market/

Obstetrics Devices Market: Product Type Insights
Based on product type, the market is segmented into retractors, delivery forceps, and suction pumps, among others. Suction pumps are projected to grow at a significant CAGR over the years. This can be associated with increasing preference for vacuum extraction when complex vaginal delivery is anticipated.

The delivery forceps are anticipated to grow at a steady rate in the coming years. Forceps allow the doctor to reach the baby quicker. This easy access is estimated to lessen the risk of birth injuries, such as seizures. However, factors such as superficial and temporary birth injuries to the baby are likely to affect the growth rate.

Obstetrics Devices Market: Regional Insights
The Asia Pacific is likely to dominate the overall obstetrics devices market over the forecast period. The regional growth is attributed to rising adoption of government programs for delivering healthy babies and for improving mother’s health. The growing awareness towards risks associated with delivery and rising infant mortality rates is also likely to increase preference for safe delivery facilities. Demand is expected to rise from countries such as India, Bangladesh, Indonesia, and China among others.


Obstetrics Devices Market

Obstetrics Devices Market: End-Use Landscape
The end-use landscape entails a list of current and prospective consumers prevailing across the regions. This section provides company addresses, contact details, products, and regional presence of companies who are purchasing or are likely to purchase obstetrics devices over the coming years. Some leading consumers of obstetrics devices are Winnie Palmer Hospital for Women and Babies, Asklepios Klinik Barmbek, Athens Regional Medical Center, Poliklinika Fleur and Brigham and Women's Hospital.

Obstetrics Devices Market: Vendor Landscape
The report contains a chapter dedicated to vendors operating in the market, covering raw material manufactures, equipment developers, manufacturers, and distributors. The report provides these insights on a regional level. This section of the report entails contact details, experience, products manufactured/supplied, and geographical presence of companies.

Obstetrics Devices Market Share & Competitor Analysis
Some of the players operating in the global obstetrics devices market include Boston Scientific Corporation, Cook Group Inc, Cooper Surgical, Ethicon Inc., Hologic, Inc., Karl StorzGmbH & Co. KG., Medtronic PLC., Olympus Corporation, Stryker and Richard Wolf GmbH.

In June 2018, Clinical Innovations announced acquisition of JB Medical Supplies. Along with strengthening Clinical Innovations’ position in the Australian market, the deal is also projected to support the company’s broader global growth strategy.

In February 2013, CooperSurgical announced release of MityOne Vacuum-Assisted Delivery (VAD) System for vaginal and C-section deliveries. The VAD device is available in bell and mushroom-style cups. The interface which consists of a self-limiting vacuum with shorter stem and gentle cup ensures the device is safe, effective and user-friendly.

Check our annual research partnership services at: https://www.globalmarketestimates.com/annual-research-partnership-services/